Effect of Estradiol Pretreatment on Antagonist ICSI Cycles

Status Completed

Clinical Trial Summary

Depended on the hypothesis that growth asynchrony of antral follicles is a consequence of the gradual follicle stimulating hormone (FSH) elevation that occurs during the late luteal phase, the aim of this work is to study the effect of estradiol pretreatment on follicular synchronization and intracytoplasmic sperm injection (ICSI) outcome in antagonist cycles

Clinical Trial Description

Gonadotropin-releasing hormone antagonist (GnRH-ant) cycles are characterized by higher patient acceptability with more attention being directed to the potential effect of steroid pretreatment to program antagonist protocol cycles, as marked size discrepancies of growing follicles reflect incoordinated maturation of follicular-oocyte complexes and complicates clinical criteria for human chorionic gonadotropin (hCG) administration. This phenomenon is associated with fewer mature oocytes and resulting embryos, which limits sufficient embryo selection for embryo transfer. Indeed, the large number of available embryos represented an important prognostic factor of invitro-fertilization (IVF) outcome, particularly in poor prognosis patients, possibly by increasing the probability that at least one good-quality embryo will be selected for embryo transfer. During COH, a better understanding of follicular development has resulted in the improvement of strategies for ovarian stimulation. This approach represents a potential and more physiological alternative to GnRH agonist or oral contraceptive pills pre-treatment in a trial to synchronize multi-follicular development and improve controlled ovarian hyperstimulation (COH) results. The present study is a randomized controlled trial that investigated whether E2 pre-treatment during the luteal phase affects developmental characteristics of growing follicles during COH. It depended on the hypothesis that growth asynchrony of antral follicles is a consequence of the gradual FSH elevation that occurs during the late luteal phase, thus testing for detection of the effect of luteal estradiol on follicular synchronization and its effect on ICSI outcome. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05197374
Study type	Interventional
Source	Alexandria University
Contact
Status	Completed
Phase	Phase 4
Start date	June 1, 2020
Completion date	November 15, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06239051` - Greening the Humanitas Fertility Center: How to Build a More Sustainable Medical Daily Routine
Recruiting	`NCT05179993` - Detection of Microplastics in Human Granulosa Cells and in the Follicular Fluid of Women Undergoing ICSI Treatment
Recruiting	`NCT03767569` - Myo-inositol as Pretreatment in Hyperandrogenic PCOS Patients	Phase 3
Completed	`NCT03737253` - Hormone Evaluation in Artificial Reproductive Technology	Phase 4
Not yet recruiting	`NCT02237755` - Clomiphene Citrate in Combination With Gonadotropins for Ovarian Stimulation in Women With Poor Ovarian Response.	Phase 2/Phase 3
Not yet recruiting	`NCT02237781` - Levels of Anti-Mullerian Hormone (AMH) During Ovarian Stimulation With Gonadotropins	Phase 2/Phase 3
Completed	`NCT01477073` - Multiple Dose FSH-GEX(TM) in Healthy Volunteers	Phase 1
Recruiting	`NCT00119925` - 'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"	N/A
Recruiting	`NCT06098495` - Looking for a Blood Epigenetic Signature to Predict Female Infertility
Completed	`NCT03998553` - Study for Obtaining Mature Oocytes by in Vitro Maturation in Oocyte-donor Women	N/A
Completed	`NCT05189145` - Hormonal Monitoring and Progesterone Adjustment in Frozen Embryo Transfer Cycles	N/A
Recruiting	`NCT05050747` - Study to Assess the Effect of Intrauterine Adminstration of HCG Versus Endometrial Injury by Pipelle
Completed	`NCT01620346` - Intracytoplasmic Morphologically Selected Sperm Injection and Advanced Maternal Age	N/A
Completed	`NCT00315029` - Patient-Centered Implementation Trial for Single Embryo Transfer	N/A
Recruiting	`NCT03080584` - Effect of 12 Weeks of Acupuncture on AMH and COH in Low Responder Patients	N/A
Not yet recruiting	`NCT05106712` - Vitamin D Supplementation and Improvement of PCOS Therapy and IVF Outcomes in Infertile Saudi Women	N/A
Recruiting	`NCT06041204` - Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism	N/A
Completed	`NCT02328924` - There is a Value of Luteinizing Hormone Predictive of in Vitro Fertilization Treatment Outcome in Antagonist Protocols?	Phase 4
Completed	`NCT01604044` - Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial.	Phase 1
Completed	`NCT04019899` - Myo-inositol and Vitamin D3 During IVF	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.